Dopamine has been shown to inhibit tumor angiogenesis and impede the invasion and migration of GC by suppressing VEGFR-2 phosphorylation and the EGFR/AKT/MMP-13 signaling pathway [29]. This evidence concerns the gene AKT1 and gastric cancer.